No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
OncoVAX is a type of cancer vaccine that is designed to stimulate the body's immune system to recognize and attack cancer cells. It is a form of immunotherapy, which is a type of treatment that uses the body's own immune system to fight cancer. OncoVAX is designed to target specific cancer cells, while leaving healthy cells unharmed. It is typically used in combination with other treatments, such as chemotherapy and radiation therapy.
OncoVAX is still in the early stages of development, and is not yet widely available. Clinical trials are ongoing to evaluate its safety and efficacy. It is expected that OncoVAX will eventually become a viable treatment option for many types of cancer.
Some companies in the OncoVAX market include Immunovaccine, Inc., OncoVax, Inc., and Oncolytics Biotech, Inc. Show Less Read more
